Eisai Innovation, Inc.
Corporate VCSan Francisco Β· 2 people tracked
Investment thesis
Eisai Innovation, Inc. is the corporate venture investment arm of pharmaceutical company Eisai, founded in 2019. It invests in biotech and digital health startups, including those spun out of academia, to build strategic ties between the scientific community and Eisai's business. The firm operates from San Francisco and Boston.
Team Β· 2 people
from the firm's websiteFrequently asked questions
- What sectors does Eisai Innovation, Inc. focus on?
- Eisai Innovation, Inc. focuses on Biotech, Digital Health, Healthtech.
- Where is Eisai Innovation, Inc. located?
- Eisai Innovation, Inc. is headquartered in San Francisco, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.